Nippon India Pharma Fund(G)

248.65 2.75 (1.12%) NAV as on 02-Mar-21
52-Week High ( ) 263.76 (11-Jan-21)
52-Week Low ( ) 130.37 (23-Mar-20)
Type Open ended scheme
Launch Date 05-Jun-04
Net Assets ( Cr ) 4197.03
Max Entry Load (%) 0.00
Max Exit Load (%) 0.00
Minimum Investment ( ) 5000

PERFORMANCE

Returns 6M (%) 1Y (%) 3Y (%) Since INC.
Scheme Return14.5561.6820.9321.15
Category Avg13.3858.3018.2522.62
Category Best-0.765.063.2019.46
Category Worst-6.89-3.39-6.39-4.00
SENSEX28.1530.1713.55-
BSE HC12.7456.7714.63-
NIFTY28.6931.7812.17-

Performance GRAPH

More from Perfomance »

Portfolio Summary

Name of Holding Instrument Hold (%)
Sun Pharmaceutical Industries Ltd.Domestic Equities11.17
Aurobindo Pharma Ltd.Domestic Equities10.78
Cipla Ltd.Domestic Equities9.84
Lupin Ltd.Domestic Equities9.12
Dr. Reddys Laboratories Ltd.Domestic Equities8.77
More from Portfolio Summary »

INvestment Pattern Details

Type Minimum Maximum
Equity and Equity related Instruments of companies in Pharma Sector80100
Debt & MMI020
Units issued by REITs and InvITs010
More from Investment Pattern Details »

Return Calculator

MARKET STATS As on 02/03/2021 As on 02/03/2021

14919.10 (1.07) 50296.89 (0.90)

TOP GAINERS

Company Price Change Gain (%)
Wanbury108.5068.50171.25
Vardhman Holdings1976.40329.4020.00

TOP LOSERS

Company Price Change Loss (%)
JIK Industries0.25-0.05-16.67
Consolidated Constn.0.40-0.05-11.11

Portfolio Comparison

MUTUAL FUND ACTIVITY